So the change in impedance could be due to mitochondrial dysfunction. That appears to leave a lot of symptoms unexplained. Like why is standing or lifting your hands above your head so hard? We need an answer that ties mitochondiral dysfunction to the vascular symptoms.
I went looking for one and found a beauty.
This study not only shows a link between mitochondrial dysfunction and imparied vasodilation, it implicates extracellular vesicles (e.g. exosomes) as the link between those two! And it also talks about ceramides and sphingolipids, which Naviaux found were at unusual levels in ME/CFS.
Am J Physiol Heart Circ Physiol. 2017 May 1; 312(5): H1096–H1104.
Published online 2017 Feb 17. doi:
10.1152/ajpheart.00680.2016
Vascular Biology and Microcirculation
Mitochondria-regulated formation of endothelium-derived extracellular vesicles shifts the mediator of flow-induced vasodilation
Julie K. Freed,
1,7
Matthew J. Durand,2,7
Brian R. Hoffmann,3,4,7
John C. Densmore,5
Andrew S. Greene,4,6,7 and
David D. Gutterman3,7
Abstract
To examine the effect of
endothelium-derived extracellular vesicles (eEVs) on the mediator of flow-induced dilation (FID), composition, formation, and functional effects on the mediator of FID were examined from two different eEV subtypes, one produced from ceramide, while the other was produced from plasminogen-activator inhibitor 1 (PAI-1). Using video microscopy, we measured internal-diameter changes in response to increases in flow in human adipose resistance arteries acutely exposed (30 min) to eEVs derived from cultured endothelial cells exposed to ceramide or PAI-1. FID was significantly impaired following exposure to 500K/ml (K = 1,000) of ceramide-induced eEVs (Cer-eEVs) but unaffected by 250K/ml. FID was reduced in the presence of PEG-catalase following administration of 250K/ml of Cer-eEVs and PAI-1 eEVs, whereas
Nω-nitro-l-arginine methyl ester (l-NAME) had no effect.
Pathway analysis following protein composition examination using liquid chromatography tandem mass spectrometry (LC-MS/MS) demonstrated that both subtypes were strongly linked to similar biological functions, primarily,
mitochondrial dysfunction. Flow cytometry was used to quantify eEVs in the presence or absence of l-phenylalanine-4′-boronic acid (PBA) and mitochondria-targeted [93-boronophenyl)methyl]triphenyl-phosphonium (mito-PBA), cytosolic and mitochondrial-targeted antioxidants, respectively. eEV formation was significantly and dramatically reduced with mito-PBA treatment. In conclusion, eEVs have a biphasic effect, with higher doses impairing and lower doses shifting the mediator of FID from nitric oxide (NO) to hydrogen peroxide (H2O2). Despite differences in protein content, eEVs may alter vascular function in similar directions, regardless of the stimulus used for their formation. Furthermore, mitochondrial ROS production is required for the generation of these vesicles.
FULL TEXT ON PMC HERE
I'm unsure of just how this fits in but it seemed too good not to share.
![Smile :) :)](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)